# Minor trauma-induced eccrine porocarcinoma of the toe in a patient on long-term carbamazepine: a case report and literature review

**Authors:** Lianbo Yang, Jinghang Lv, Xinghan Zhao, Ziang Zheng, Xinyao Cui, Jiabin Lin, Yifan Wang, Haidong Liang

PMC · DOI: 10.3389/fonc.2026.1727762 · Frontiers in Oncology · 2026-02-13

## TL;DR

A rare case of toe cancer in a man on long-term epilepsy medication is reported, highlighting the need for early diagnosis and possible drug-related factors.

## Contribution

Reports a rare case linking long-term carbamazepine use with eccrine porocarcinoma following minor trauma.

## Key findings

- A 51-year-old male on long-term carbamazepine developed eccrine porocarcinoma after minor toe trauma.
- Histopathology confirmed the diagnosis after amputation due to a non-healing ulcerative mass.
- The case suggests a potential link between carbamazepine and tumor development via chronic inflammation.

## Abstract

Eccrine Porocarcinoma is a rare malignant neoplasm of eccrine sweat gland origin. Its diverse clinical presentation often leads to misdiagnosis and delayed treatment. The potential role of systemic factors, such as long-term medication use, in its pathogenesis is poorly understood.

We report a case of a 51-year-old male with a 30-year history of epilepsy on long-term carbamazepine therapy, who developed a refractory ulcerative mass on the left second toe after minor trauma. Toe amputation was performed, and histopathology confirmed Eccrine Porocarcinoma.

This case highlights the importance of considering rare malignancies like Eccrine Porocarcinoma in the differential diagnosis of non-healing acral ulcers. An early biopsy is crucial. The long-term use of carbamazepine in this context is noted, and its potential role as a co-factor in tumor development, possibly interacting with local chronic inflammation, is discussed. Further investigation into the influence of systemic medications on the pathogenesis of such rare tumors is warranted.

## Linked entities

- **Chemicals:** carbamazepine (PubChem CID 2554)
- **Diseases:** epilepsy (MONDO:0005027), eccrine porocarcinoma (MONDO:0006189)

## Full-text entities

- **Genes:** CEACAM3 (CEA cell adhesion molecule 3) [NCBI Gene 1084] {aka CD66D, CEA, CGM1, CGM1a, W264, W282}, CYP3A5 (cytochrome P450 family 3 subfamily A member 5) [NCBI Gene 1577] {aka CP35, CYPIIIA5, P450PCN3, PCN3}, NUTM1 (NUT midline carcinoma family member 1) [NCBI Gene 256646] {aka C15orf55, FAM22H, NUT}, RB1 (RB transcriptional corepressor 1) [NCBI Gene 5925] {aka OSRC, PPP1R130, RB, p105-Rb, p110-RB1, pRb}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, MAML2 (mastermind like transcriptional coactivator 2) [NCBI Gene 84441] {aka MAM-3, MAM2, MAM3, MLL-MAML2}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}
- **Diseases:** DRESS syndrome (MESH:D063926), infection (MESH:D007239), adenocarcinoma (MESH:D000230), acral malignancies (MESH:D009369), onychomycosis (MESH:D014009), adnexal tumor of the skin (MESH:D018294), poroid neoplasms (MESH:C000613206), chronic infectious granulomas (MESH:D006506), ulcer (MESH:D014456), swelling (MESH:D004487), trauma (MESH:D014947), HL (MESH:C538324), chronic inflammation (MESH:D007249), epilepsy (MESH:D004827), acral ulcers (MESH:C000721267), metastasis (MESH:D009362), wart (MESH:D014860), malnutrition (MESH:D044342), pyogenic granuloma (MESH:D017789), skin conditions (MESH:D012871), skin injury (MESH:D000069836), immune dysregulation (OMIM:614878), seizure (MESH:D012640), MCC (MESH:D015266), necrosis (MESH:D009336), basal cell carcinoma (MESH:D002280), SCC (MESH:D002294), ulcerative mass (MESH:C536030), toe injury (MESH:D000070592), SJS/TEN (MESH:D013262), systemic diseases (MESH:D034721), Lymph node metastasis (MESH:D008207), chronic pain (MESH:D059350), scars (MESH:D002921), cutaneous malignancies (MESH:C562393), adnexal tumors (MESH:D000292), hypoalbuminemia (MESH:D034141), osteomyelitis (MESH:D010019), Eccrine Porocarcinoma (MESH:D057090), tumorigenesis (MESH:D063646)
- **Chemicals:** vitamin D (MESH:D014807), H&amp;E (MESH:D006371), carbamazepine (MESH:D002220)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945823/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945823/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945823/full.md

---
Source: https://tomesphere.com/paper/PMC12945823